Media reports claiming that expired vaccines are being administered in India are false and misleading, stated a Ministry of Health and Family Welfare release on Monday. ...
The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials. ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 booster dose, said sources on Thursday. ...
Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body. ...
Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in India. ...
US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (chil ...
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of mixing COVID-19 vaccines--Covaxin and Covishield--said sources. ...
